If you're using commsec look at the recommendations and click on the goldman sachs report. It indicates % via upside + downside with a 12 month valuation of $5.2 as of June 10 after the results had been released the price was $3.05
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME, page-94
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.015(3.90%) |
Mkt cap ! $486.2M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 40.0¢ | 38.5¢ | $165.6K | 421.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 44387 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 150395 | 11 |
View Market Depth
| Last trade - 10.55am 24/07/2024 (20 minute delay) ? |
| OPT (ASX) Chart |